Aug 23 |
Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
|
Aug 22 |
Jazz Pharma Epidyolex phase 3 trial fails in Japan
|
Aug 22 |
Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies
|
Aug 21 |
Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
|
Aug 19 |
A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
|
Aug 15 |
Axsome (AXSM) Banks on Auvelity & Sunosi to Fuel Growth
|
Aug 9 |
AMNEAL PHARMACEUTICALS, INC. (AMRX) Soars to 52-Week High, Time to Cash Out?
|
Aug 8 |
Shareholders Will Be Pleased With The Quality of Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings
|
Aug 6 |
JAZZ or CTLT: Which Is the Better Value Stock Right Now?
|
Aug 6 |
Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade
|